SARS-CoV-2

A unique RNA structure shared across SARS-CoV-2 variants may contribute to viral fitness, offering a potential target for new antiviral treatments.

Antibodies in mucous membranes may be key in protecting against SARS-CoV-2 variants, pointing to the need for COVID-19 vaccines that target these antibody responses.

A high-resolution study of SARS-CoV-2 antibodies revealed how they neutralise variants and reduce the impact of spike protein mutations.

A two-year study uncovers potential immune biomarkers to detect long COVID, and evidence that its inflammatory symptoms may resolve over time.

While the new Omicron XBB COVID-19 subvariant deftly dodges immune defences even in vaccinated individuals, researchers find that mixed mRNA vaccines may offer a vital boost of protection.

A novel machine learning framework enables data sharing for pandemic management while safeguarding patient privacy.

A study reveals how age, SARS-CoV-2 variants and booster shots affect immune responses to the COVID-19 vaccine.

Investigations into an under-explored region of SARS-CoV-2’s spike protein reveals detailed structural insights that can represent valuable drug targets.

A new genetically-modified mouse model offers a powerful and reliable platform to study human immune responses to complex infections.

Wastewater surveillance in epidemiological studies can help researchers better understand and control COVID-19 outbreaks.

A surge in Singapore’s bike-sharing usage during the COVID-19 pandemic highlights the importance of shared mobility modes during periods of restricted public transit.

With near-real-time genomic monitoring, researchers catch emergent, treatment-evading SARS-CoV-2 mutations in immunocompromised patients with chronic infections.